- BeiGene receives its first FDA approval
- I-Mab to kick off clinical trials for monoclonal antibody TJM2 in China
- FDB invests $55M to expand gene therapy process
- Samsung Biologics enhances its trusted service
- 111 to establish healthcare retail channel with HEC
- Takeda announces 12 new molecular entities
- International Diabetes Federation reports 463 Million Diabetics Worldwide
- Duke-NUS’ mobile health programme simplifies T2DM health outcomes
- Abbott partners with Diabetes Singapore
- NEC, VAXIMM to advance personalized neoantigen cancer vaccines
- ASN showcases Singapore-led global diabetes study
- Global BioLife to Present 3F Antimicrobial Fragrance at 2020 ASM Biothreats
- Biocon Biologics Debuts on the ASIA IP ELITE 2019 List
- Philips launches AI based clinical product for aiding cognitive assessment
-
Singapore | 04 July 2019 | News
Latest technologies to transform healthcare
A new consortium led by the Institute for Health Innovation and Technology (iHealthtech) at NUS will tap on th...Read more
Europe | 05 November 2019 | Influencers
TPP Commits To Transform The Delivery of Health and Care Globally
Nov Special Interview - Malaysia. TPP is a healthcare technology company, dedicated to delivering world...Read more
-
China | 15 November 2019 | News
I-Mab to kick off clinical trials for monoclonal antibody TJM2 in China
I-Mab Biopharma ("I-Mab"), a China and U.S.-based clinical-stage biopharmaceutical company exclusive...Read more
-
India | 13 November 2019 | News
Biocon Biologics Debuts on the ASIA IP ELITE 2019 List
Biocon Ltd, an innovation-led global biopharmaceuticals company, has announced that it has been recognise...Read more
-
Middle East countries | 16 July 2019 | News
Filterlex Medical raises $3M in Series A Financing
Filterlex Medical is a medical device start-up company based in Israel, developing an innovative embolic ...Read more
-
Thailand | 30 July 2019 | News
Thai startups to capture a major chunk of healthcare market
The medical device market in ASEAN is predicted to be worth US$8.5 billion by 2021, and Thai entrepreneurs wan...Read more
Needs much more for world without diabetes
Diabetes is on the rise across the globe as reported in the most recent 8th edition of the International Diabetes Federation (IDF) Diabetes Atlas 2017. As Diabetes is a lifestyle disease, it can be prevented by adopting appropriate lifestyle. This is what the evidence from studies conducted in the USA, Finland, China, India and Japan have proved. However, the pharma industry has been investing on R&D and launching new products but needs much more. From January 2019 to October 31, 2019, the US FDA has approved three products for type 2 diabetes (two drugs Rybelsus and Victoza from Novo Nordisk and one drug – Farxiga from AstraZeneca).
